X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
corticosteroid-induced osteoporosis (622) 622
humans (453) 453
osteoporosis (299) 299
female (290) 290
male (240) 240
bone-mineral density (218) 218
osteoporosis - chemically induced (217) 217
glucocorticoids - adverse effects (208) 208
endocrinology & metabolism (200) 200
glucocorticoid-induced osteoporosis (189) 189
middle aged (183) 183
rheumatology (179) 179
prevention (175) 175
bone density - drug effects (158) 158
index medicus (151) 151
rheumatoid-arthritis (146) 146
aged (139) 139
double-blind (138) 138
osteoporosis - drug therapy (137) 137
osteoporosis - prevention & control (134) 134
adult (132) 132
bone density (126) 126
glucocorticoids (122) 122
postmenopausal women (122) 122
corticosteroids (116) 116
risk factors (113) 113
therapy (113) 113
alendronate (102) 102
fractures (100) 100
diphosphonates - therapeutic use (97) 97
bone density conservation agents - therapeutic use (96) 96
medicine, general & internal (91) 91
animals (89) 89
mineral density (85) 85
bone mineral density (83) 83
calcium (81) 81
bisphosphonates (80) 80
vertebral fracture (80) 80
postmenopausal osteoporosis (77) 77
steroid-induced osteoporosis (72) 72
vitamin d (72) 72
oral corticosteroids (70) 70
orthopedics (67) 67
medicine & public health (64) 64
vitamin-d (62) 62
glucocorticoids - therapeutic use (61) 61
absorptiometry, photon (60) 60
risedronate (60) 60
management (59) 59
steroids (59) 59
hormone replacement therapy (57) 57
parathyroid-hormone (57) 57
vertebral fractures (57) 57
induced bone loss (55) 55
osteoporosis - physiopathology (55) 55
alfacalcidol (53) 53
glucocorticoid (52) 52
women (52) 52
bones (51) 51
pharmacology & pharmacy (51) 51
drug therapy (50) 50
osteoporosis - etiology (50) 50
osteoporosis - therapy (50) 50
adolescent (49) 49
fracture (49) 49
vitamin d - therapeutic use (49) 49
osteoporosis - diagnosis (48) 48
care and treatment (47) 47
fractures, bone - prevention & control (47) 47
bone (46) 46
treatment outcome (45) 45
intermittent cyclical etidronate (44) 44
risk (44) 44
bone and bones - drug effects (43) 43
bone loss (42) 42
osteoporosis - complications (42) 42
cyclical etidronate (41) 41
density (41) 41
glucocorticoids - administration & dosage (41) 41
salmon-calcitonin (41) 41
aged, 80 and over (40) 40
etidronic acid - therapeutic use (39) 39
randomized controlled-trial (39) 39
bone and bones - metabolism (38) 38
bone density - physiology (38) 38
alendronate - therapeutic use (37) 37
endocrinology (37) 37
induced osteopenia (37) 37
complications and side effects (36) 36
fractures, bone - etiology (36) 36
osteoporosis - epidemiology (36) 36
placebo-controlled trial (36) 36
calcitonin (35) 35
calcium - therapeutic use (35) 35
adrenal cortex hormones - adverse effects (34) 34
drug therapy, combination (33) 33
osteoporosis, postmenopausal - drug therapy (33) 33
double-blind method (32) 32
rats (32) 32
prospective studies (31) 31
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (636) 636
German (24) 24
French (11) 11
Spanish (5) 5
Polish (2) 2
Russian (2) 2
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, ISSN 0889-857X, 02/2007, Volume 33, Issue 1, pp. 149 - 149
Journal Article
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 09/2015, Volume 173, Issue 3, pp. R131 - R151
Journal Article
CLINICS IN GERIATRIC MEDICINE, ISSN 0749-0690, 08/2005, Volume 21, Issue 3, pp. 603 - 603
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 20, pp. 2028 - 2039
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 06/2013, Volume 28, Issue 6, pp. 1355 - 1368
ABSTRACT Data on treatment of glucocorticoid‐induced osteoporosis (GIO) in men are scarce. We performed a randomized, open‐label trial in men who have taken... 
GLUCOCORTICOID‐INDUCED OSTEOPOROSIS | BONE MINERAL DENSITY | BONE MICROSTRUCTURE | VERTEBRAL FRACTURE | FINITE ELEMENT ANALYSIS | MALE OSTEOPOROSIS | HIGH RESOLUTION QUANTITATIVE COMPUTED TOMOGRAPHY | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | QUANTITATIVE COMPUTED-TOMOGRAPHY | CORTICOSTEROID-INDUCED OSTEOPOROSIS | FRACTURE RISK | ALENDRONATE | TRABECULAR BONE | THERAPY | ENDOCRINOLOGY & METABOLISM | PARATHYROID-HORMONE | POSTMENOPAUSAL WOMEN | VERTEBRAL MICROSTRUCTURE | FINITE-ELEMENT-ANALYSIS | Glucocorticoids - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Osteoporosis - drug therapy | Spinal Fractures - metabolism | Osteoporosis - metabolism | Osteoporosis - diagnostic imaging | Aged, 80 and over | Adult | Female | Risedronate Sodium | Etidronic Acid - analogs & derivatives | Glucocorticoids - adverse effects | Etidronic Acid - administration & dosage | Lumbar Vertebrae - metabolism | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Lumbar Vertebrae - diagnostic imaging | Teriparatide - administration & dosage | Europe | Bone Density Conservation Agents - administration & dosage | Spinal Fractures - diagnostic imaging | Radiography | Bone Density - drug effects | Aged | Osteoporosis | Corticosteroids | Comparative analysis | Steroids | Tomography | Bone density | Original
Journal Article
Calcified Tissue International, ISSN 0171-967X, 10/2012, Volume 91, Issue 4, pp. 225 - 243
Journal Article